Positive End-of-Phase 2 meeting with the FDA for entospletinib in newly diagnosed NPM1-mutated acute myeloid leukemia First patient dosed in Phase 1/2 trial of KB-0742,
Tag: Bio
Yokogawa Establishes Yokogawa Bio Frontier Inc. to Progress Biomass Resources Business enterprise
Bloomberg Scion of Billionaire Family members Hunts for Low-priced Belongings in Venezuela (Bloomberg) — The identify Cisneros is synonymous with organization acumen and opulence in
Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update
Closed business combination with Panacea, yielding new public listing and strong cash position of approximately $830 million Patient enrollment ongoing in Phase 1/2 study of
JS Bio and Etta Biotech Advancing Strategic Partnership | Business enterprise & Finance
THOUSAND OAKS, Calif. & SHANGHAI–(Business WIRE)–Jan 17, 2021– Jianshun Biosciences Co., Ltd. (“JS Bio”) lately introduced its strategic partnership with Etta Biotech Co., Ltd. (“Etta